Ranpura V, Hapani S, Chuang J, Wu S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials. AO [Internet]. 2010 Jan. 1 [cited 2026 Apr. 30];49(3):287-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32546